ask="9.90"
ask_size="100"
average_daily_volume="43919"
bid="7.80"
bid_size="200"
book_value="-19.19"
change="-0.68"
change_from_200_day_moving_average="0.22"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-36.32"
change_From_52_week_low="1.69"
change_in_percent="-8.04%"
close="7.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="8.95"
high_52_weeks="44.10"
last_trade_date="1/11/2017"
last_trade_price="7.78"
last_trade_size="263"
last_trade_time="3:58pm"
low="7.51"
low_52_weeks="6.09"
market_capitalization="18.96M"
moving_average_200_day="7.56"
moving_average_50_day="7.57"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="8.77"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.92%"
percent_change_from_50_day_moving_average="+2.74%"
percent_change_from_52_week_high="-82.36%"
percent_change_from_52_week_low="+27.75%"
previous_close="8.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="11.63"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="0.43"
stock_exchange="NGM"
symbol="KALV"
volume="97520"
weeks_range_52="6.09 - 44.10"
